About Sister chromatid cohesion protein DCC1
Sister chromatid cohesion protein DCC1 (DSCC1) is a protein
from Homo sapiens identified by UniProt accession
Q9BVC3, 393 residues long.
MolForge cross-references it against 0 known binders and
61 disease associations.
Target properties
| Protein name | Sister chromatid cohesion protein DCC1 |
| UniProt accession | Q9BVC3 |
| Gene | DSCC1 |
| Organism | Homo sapiens |
| Length | 393 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (61)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.43
- body height · score 0.18
- mean corpuscular volume · score 0.13
- Myocardial Ischemia · score 0.10
- platelet crit · score 0.10
- lung adenocarcinoma · score 0.09
- mean reticulocyte volume · score 0.09
- red blood cell density measurement · score 0.09
- hepatocellular carcinoma · score 0.08
- BMI-adjusted hip circumference · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BVC3-F1 | alphafold | PREDICTED | 91.59 | — |
Amino-acid sequence (393 residues)
MKRTRDEVDA TLQIAKLNAA ELLPAVHCLG FGPGASGAAA GDFCLLELEP TLCQQLEDGH SLVIRGDKDE QAVLCSKDKT YDLKIADTSN MLLFIPGCKT PDQLKKEDSH CNIIHTEIFG FSNNYWELRR RRPKLKKLKK LLMENPYEGP DSQKEKDSNS SKYTTEDLLD QIQASEEEIM TQLQVLNACK IGGYWRILEF DYEMKLLNHV TQLVDSESWS FGKVPLNTCL QELGPLEPEE MIEHCLKCYG KKYVDEGEVY FELDADKICR AAARMLLQNA VKFNLAEFQE VWQQSVPEGM VTSLDQLKGL ALVDRHSRPE IIFLLKVDDL PEDNQERFNS LFSLREKWTE EDIAPYIQDL CGEKQTIGAL LTKYSHSSMQ NGVKVYNSRR PIS
Explore Sister chromatid cohesion protein DCC1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets